Filing Details
- Accession Number:
- 0001209191-14-027652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-15 18:19:32
- Reporting Period:
- 2014-04-11
- Filing Date:
- 2014-04-15
- Accepted Time:
- 2014-04-15 18:19:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 944809 | Opko Health Inc. | OPK | Pharmaceutical Preparations (2834) | 752402409 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1381874 | D Steven Rubin | Opko Health, Inc. 4400 Biscayne Blvd. Miami FL 33137 | Executive Vp-Administration | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-11 | 500,000 | $4.88 | 4,769,855 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-04-11 | 200,000 | $1.65 | 4,969,855 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-11 | 312,289 | $8.87 | 4,657,566 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-04-14 | 100,000 | $8.58 | 4,557,566 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-15 | 79,300 | $8.10 | 4,478,266 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-11 | 500,000 | $0.00 | 500,000 | $4.88 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-11 | 200,000 | $0.00 | 200,000 | $1.65 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-04-14 | 350,000 | $0.00 | 350,000 | $8.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-03 | No | 4 | M | Direct | |
| 0 | 2015-04-28 | No | 4 | M | Direct | |
| 350,000 | 2024-04-13 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,490,546 | Indirect | See Footnote |
Footnotes
- Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price in connection with the exercise of stock options. The reporting person has retained the net number of shares issued upon the exercise of the option (387,711 shares).
- Closing market price of the Company's common stock on the transaction date.
- The shares sold on April 14 and 15, 2014 were sold to pay/satisfy federal and/or state tax withholding in connection with a stock option exercise on April 11, 2014. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.82, inclusive. The reporting person undertakes to provide to OPKO Health, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.40, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
- These securities are owned directly by The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- The options were granted on May 3, 2007 and vested in four equal installments beginning on May 3, 2008.
- The options were granted on April 28, 2008 and vested in four equal installments beginning on April 28, 2009.
- This option will vest in four equal annual installments beginning April 14, 2015.
Billionaire Hedge Funds
